Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Disposable Medical Devices Sensors Market

  • MAR2979155
  • 203 Pages
  • March 2018
  • Pharmaceuticals
Download Sample    Get Discount   
 
Disposable medical devices sensors are the need of the hour because of the relative ease of use, cost-effectiveness, non-infectious nature and the major one being faster response as well as more rapid results. With increased usage of analytics in the healthcare field, efficient data gathering will play an essential role in getting adequate results. Thus, the disposable medical devices sensors will play a significant role in achieving appropriate data needs. These devices are used to measure basic vital signs such as heart rates, breathing rates, pulse transmit time, temperature, blood oxygenation levels and others where changes help in identifying an anomaly of any sort. The new technology can be credited for this expectation as various advancements are allowing companies to make distinctive devices with better features and unique services. For instance, Ibis Biosciences has developed a machine which is capable of identifying around 1000 common disease-causing pathogens within few hours of blood sample collection, accurately.

The market is expected to grow at a rate of XX% during 2017-22 from a valuation of USD XX in 2017 to USD XX in 2022.

Market Dynamics

The primary driver of the disposable medical devices sensors market is the increasing ubiquity of chronic and long-term diseases. According to World Health Organization, chronic disease prevalence is going to increase by 57% by the year 2020, a serious concern. Another significant driver is the surging concern over healthcare-associated infections and contaminations also known as Nosocomial infections. Urinary tract infections are the most common healthcare infections among all age groups. These diseases also depend on the kind of facility into which a person is admitted. Thus, disposable medical devices sensors can help in maintaining hygiene standards. Another market accelerator is the support associated with Government initiative for research and development in the healthcare industry as well as increasing investment by venture capitalist firms. Furthermore, the market is driven by rising need to reduce healthcare costs through low-cost medical devices and technology. Currently, Point-Of-Contact Testing (POCT) has helped with reduction of costs by reducing manual labor associated with healthcare. Thu, advancement in such technologies and disposable equipment related to it, will inevitably drive the market growth. However, stringent Government regulatory procedures and lack of reimbursement policies may hamper the growth of the market.

Market Segmentation

The global disposable medical devices sensors market can be segmented by product, by application, by end-user, and by geography. By product, the market can be categorized into wearable, implanted, ingestible, invasive sensors and strip sensors. The market can be divided by application into patient monitoring devices, diagnostic testing devices, therapeutic devices and imaging devices. Each category is further subdivided into at least four divisions. By end-user, the market is segmented into hospitals, diagnostic laboratories, home care and clinics. By region, we can divide the market into North America, Europe, Asia-Pacific and, Middle East and Africa.

Geographical Analysis

North America and Europe account for the majority of the market share because of established competencies in the healthcare industry. However, Asia-Pacific market will grow at the highest CAGR owing to increasing medical tourism, healthcare expenditures, raising awareness and rising per capita income.

Key Players

The crucial players in the market are Medtronic plc, GE Healthcare, Philips N.V., Smiths Medical, Freescale Semiconductors Inc., TE connectivity and Honeywell International Inc.

Report Contents:

> Market segments

> Market Drivers, Restraints and Opportunities

> Market Size & Forecast 2016 to 2022

> Supply & Demand Value Chain

> Market - Current Trends

> Competition & Major Companies

> Technology and R&D Status

> Porters Five Force Analysis

> Strategic and Critical Success Factor Analysis of Key Players

Regional Analysis:

> North America

>> US and Canada

> Latin America

>> Mexico, Brazil, Argentina and Rest of Latin America

> Western Europe

>> EU5 (Germany, France, Italy, Spain, U.K.)

>> Nordic Countries (Denmark, Finland, Norway, and Sweden)

>> Benelux (Belgium, The Netherlands, and Luxembourg)

>> Rest of Western Europe

> Eastern Europe

>> Russia

>> Poland

>> Rest of Eastern Europe

> Asia Pacific

>> China

>> India

>> Japan

>> Australia and New Zealand

>> Rest of Asia Pacific

> Middle East and Africa

>> GCC countries (Saudi Arabia, Oman, Qatar, Bahrain, UAE and Kuwait)

>> South Africa

>> North Africa

>> Rest of Middle East and Africa

This report is an elaborate aggregation of primary inputs from industry experts and participants across the supply chain. It provides details on market segmentation which is derived from several product mapping exercises, macroeconomic parameters and other qualitative and quantitative insights. The impact of all such factors is delivered across multiple market segments and geographies.

Report Highlights:

> Detailed Historical Overview (Market Origins, Product Launch Timeline, etc.)

> Consumer and Pricing Analysis

> Market dynamics of the industry

> Market Segmentation

> Estimated Market Sizing in terms of volume and value

> Recent trends in Market and impact

> Research Status and Technology Overview

> Extensive Industry Structure Coverage

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390